Cargando…

Assessing the effectiveness of Chagas disease education for healthcare providers in the United States

BACKGROUND: Chagas disease is a zoonotic infection caused by the parasite Trypanosoma cruzi, which affects an estimated 8–11 million people globally. Chagas disease is almost always associated with poverty in rural areas and disproportionately impacts immigrants from Latin America living in the Unit...

Descripción completa

Detalles Bibliográficos
Autores principales: Stigler Granados, Paula, Pacheco, Gerardo J., Núñez Patlán, Evangelina, Betancourt, Jose, Fulton, Lawrence
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7547496/
https://www.ncbi.nlm.nih.gov/pubmed/33036559
http://dx.doi.org/10.1186/s12879-020-05474-w
_version_ 1783592433046519808
author Stigler Granados, Paula
Pacheco, Gerardo J.
Núñez Patlán, Evangelina
Betancourt, Jose
Fulton, Lawrence
author_facet Stigler Granados, Paula
Pacheco, Gerardo J.
Núñez Patlán, Evangelina
Betancourt, Jose
Fulton, Lawrence
author_sort Stigler Granados, Paula
collection PubMed
description BACKGROUND: Chagas disease is a zoonotic infection caused by the parasite Trypanosoma cruzi, which affects an estimated 8–11 million people globally. Chagas disease is almost always associated with poverty in rural areas and disproportionately impacts immigrants from Latin America living in the United States. Approximately 20–30% of people who are infected with Chagas disease will develop a chronic form of the infection that can be fatal if left untreated. Chagas disease is vastly underestimated in the United States, often goes undiagnosed and is not well understood by most U.S. healthcare providers. One of the most important ways at reducing barriers to improving diagnostics of Chagas disease in the U.S. is giving healthcare providers the most up-to-date information and access to leading experts. METHODS: An online webinar was conducted for healthcare providers, veterinarians and public health professionals using Chagas disease expert panelists. Pre and post tests were administered to participants (n = 57) to determine the efficacy in raising awareness and to determine key focus areas for improving knowledge. A Wilcoxon rank-sum was used for non-parametric variables equivalent and for questions that assessed knowledge the McNemar’s Chi-Square test was used. RESULTS: There were statistically significant learning increases in multiple categories including transmission (p = <.001), clinical presentation (p = 0.016), diagnostics (p = <.001), and treatment (p = <.001). CONCLUSION: Providing easily accessible learning opportunities using validated testing and evaluations should be further developed for rural healthcare providers in the U.S. as well as healthcare providers serving under represented populations such as immigrants. There is a clear lack of knowledge and awareness surrounding Chagas disease in the United States and just by raising awareness and providing education on the topic, lives will be saved.
format Online
Article
Text
id pubmed-7547496
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-75474962020-10-13 Assessing the effectiveness of Chagas disease education for healthcare providers in the United States Stigler Granados, Paula Pacheco, Gerardo J. Núñez Patlán, Evangelina Betancourt, Jose Fulton, Lawrence BMC Infect Dis Research Article BACKGROUND: Chagas disease is a zoonotic infection caused by the parasite Trypanosoma cruzi, which affects an estimated 8–11 million people globally. Chagas disease is almost always associated with poverty in rural areas and disproportionately impacts immigrants from Latin America living in the United States. Approximately 20–30% of people who are infected with Chagas disease will develop a chronic form of the infection that can be fatal if left untreated. Chagas disease is vastly underestimated in the United States, often goes undiagnosed and is not well understood by most U.S. healthcare providers. One of the most important ways at reducing barriers to improving diagnostics of Chagas disease in the U.S. is giving healthcare providers the most up-to-date information and access to leading experts. METHODS: An online webinar was conducted for healthcare providers, veterinarians and public health professionals using Chagas disease expert panelists. Pre and post tests were administered to participants (n = 57) to determine the efficacy in raising awareness and to determine key focus areas for improving knowledge. A Wilcoxon rank-sum was used for non-parametric variables equivalent and for questions that assessed knowledge the McNemar’s Chi-Square test was used. RESULTS: There were statistically significant learning increases in multiple categories including transmission (p = <.001), clinical presentation (p = 0.016), diagnostics (p = <.001), and treatment (p = <.001). CONCLUSION: Providing easily accessible learning opportunities using validated testing and evaluations should be further developed for rural healthcare providers in the U.S. as well as healthcare providers serving under represented populations such as immigrants. There is a clear lack of knowledge and awareness surrounding Chagas disease in the United States and just by raising awareness and providing education on the topic, lives will be saved. BioMed Central 2020-10-09 /pmc/articles/PMC7547496/ /pubmed/33036559 http://dx.doi.org/10.1186/s12879-020-05474-w Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Stigler Granados, Paula
Pacheco, Gerardo J.
Núñez Patlán, Evangelina
Betancourt, Jose
Fulton, Lawrence
Assessing the effectiveness of Chagas disease education for healthcare providers in the United States
title Assessing the effectiveness of Chagas disease education for healthcare providers in the United States
title_full Assessing the effectiveness of Chagas disease education for healthcare providers in the United States
title_fullStr Assessing the effectiveness of Chagas disease education for healthcare providers in the United States
title_full_unstemmed Assessing the effectiveness of Chagas disease education for healthcare providers in the United States
title_short Assessing the effectiveness of Chagas disease education for healthcare providers in the United States
title_sort assessing the effectiveness of chagas disease education for healthcare providers in the united states
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7547496/
https://www.ncbi.nlm.nih.gov/pubmed/33036559
http://dx.doi.org/10.1186/s12879-020-05474-w
work_keys_str_mv AT stiglergranadospaula assessingtheeffectivenessofchagasdiseaseeducationforhealthcareprovidersintheunitedstates
AT pachecogerardoj assessingtheeffectivenessofchagasdiseaseeducationforhealthcareprovidersintheunitedstates
AT nunezpatlanevangelina assessingtheeffectivenessofchagasdiseaseeducationforhealthcareprovidersintheunitedstates
AT betancourtjose assessingtheeffectivenessofchagasdiseaseeducationforhealthcareprovidersintheunitedstates
AT fultonlawrence assessingtheeffectivenessofchagasdiseaseeducationforhealthcareprovidersintheunitedstates